ZSTK474, a PI3K inhibitor, suppresses proliferation and sensitizes human pancreatic adenocarcinoma cells to gemcitabine
Insoo Bae(Georgetown University)
Cited by 26
Related Papers
Inhibition of the <scp>PI</scp>3K/<scp>AKT</scp> pathway potentiates cytotoxicity of <scp>EGFR</scp> kinase inhibitors in triple‐negative breast cancer cells
|Journal of Cellular and Molecular Medicine|2013|77
CR6-interacting Factor 1 (CRIF1) Regulates NF-E2-related Factor 2 (NRF2) Protein Stability by Proteasome-mediated Degradation
|Journal of Biological Chemistry|2010|70
Inhibition of NRF2 by PIK-75 augments sensitivity of pancreatic cancer cells to gemcitabine
|International Journal of Oncology|2013|63
HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction
|Scientific Reports|2014|59
BML-275, an AMPK inhibitor, induces DNA damage, G2/M arrest and apoptosis in human pancreatic cancer cells
|International Journal of Oncology|2012|35